Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1866 1
1884 1
1889 1
1892 1
1895 1
1907 1
1918 1
1923 1
1935 1
1942 1
1943 1
1945 8
1946 41
1947 58
1948 35
1949 45
1950 29
1951 101
1952 146
1953 175
1954 176
1955 169
1956 136
1957 168
1958 143
1959 119
1960 77
1961 94
1962 123
1963 373
1964 598
1965 468
1966 459
1967 629
1968 885
1969 898
1970 871
1971 1048
1972 1126
1973 1104
1974 1263
1975 1174
1976 1210
1977 1256
1978 1290
1979 1366
1980 1305
1981 1200
1982 1280
1983 1296
1984 1502
1985 1458
1986 1440
1987 1500
1988 1527
1989 1783
1990 1820
1991 2011
1992 1990
1993 2284
1994 2484
1995 2843
1996 3071
1997 3759
1998 4139
1999 4217
2000 5406
2001 5331
2002 5843
2003 6291
2004 6853
2005 8079
2006 8760
2007 9404
2008 10273
2009 11580
2010 12690
2011 14181
2012 16357
2013 18515
2014 22089
2015 25012
2016 26810
2017 28122
2018 30138
2019 33197
2020 39327
2021 42041
2022 37190
2023 34212
2024 11843

Text availability

Article attribute

Article type

Publication date

Search Results

468,029 results

Results by year

Filters applied: . Clear all
Page 1
Associations of early-life and adult anthropometric measures with the expression of stem cell markers CD44, CD24, and ALDH1A1 in women with benign breast biopsies.
Oh H, Yaghjyan L, Heng YJ, Rosner B, Mahoney MB, Murthy D, Baker GM, Tamimi RM. Oh H, et al. Cancer Epidemiol Biomarkers Prev. 2024 Apr 23. doi: 10.1158/1055-9965.EPI-23-1567. Online ahead of print. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38652503
METHODS: The analysis included 414 women with biopsy-confirmed benign breast disease (BBD) in the Nurses' Health Study (NHS) and NHSII. Birthweight, weight at age 18, current weight, and current height were reported via self-administered questionnaire. ...
METHODS: The analysis included 414 women with biopsy-confirmed benign breast disease (BBD) in the Nurses' Health Study (NHS) and NHSI …
Supportive care measures for bispecific T-cell engager therapies in haematological malignancies.
Chen LY, Kothari J. Chen LY, et al. Curr Opin Support Palliat Care. 2024 Apr 23. doi: 10.1097/SPC.0000000000000699. Online ahead of print. Curr Opin Support Palliat Care. 2024. PMID: 38652455
RECENT FINDINGS: Currently, supportive care measures for TCEs have largely been inferred from other T-cell therapies, such as CAR-T (chimeric antigen receptor) therapy. Further research into TCE-specific supportive care measures is needed to improve the tolerability of the …
RECENT FINDINGS: Currently, supportive care measures for TCEs have largely been inferred from other T-cell therapies, such as CAR-T (chimeri …
Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii.
Rehem AR, da Gama Viveiro LR, De Souza Santos EL, do Carmo PHF, da Silva NS, Junqueira JC, Scorzoni L. Rehem AR, et al. Folia Microbiol (Praha). 2024 Apr 23. doi: 10.1007/s12223-024-01164-1. Online ahead of print. Folia Microbiol (Praha). 2024. PMID: 38652436
In addition, DH exhibited fungicidal activity ranging from 15.62 to 250 g/mL. ...In conclusion, DH showed promising antifungal activity against planktonic cells and biofilms of C. neoformans and C. gattii, opening perspectives for further studies with DH in v …
In addition, DH exhibited fungicidal activity ranging from 15.62 to 250 g/mL. ...In conclusion, DH showed promising antifungal …
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape.
Ghose A, Lapitan P, Apte V, Ghosh A, Kandala A, Basu S, Parkes J, Shinde SD, Boussios S, Sharma A, Das P, Vasdev N, Rebuzzi SE, Ürün Y, Kanesvaran R, Maniam A, Banna GL. Ghose A, et al. Curr Oncol Rep. 2024 Apr 23. doi: 10.1007/s11912-024-01524-7. Online ahead of print. Curr Oncol Rep. 2024. PMID: 38652426 Review.
ADCs have emerged as a pivotal innovation in oncology, blending targeted antibody therapy with potent cytotoxic drugs, significantly advancing treatment options for urological malignancies....
ADCs have emerged as a pivotal innovation in oncology, blending targeted antibody therapy with potent cytotoxic drugs, significantly …
468,029 results
You have reached the last available page of results. Please see the User Guide for more information.